MICHAEL KAPLOWITZ: Open Payments
NPI 1255308078 · RIVERDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 21 payments from 10 companies in 2025. Trend: 2023 $651 · 2024 $206 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $308 |
| Teva Pharmaceuticals USA, Inc. | 5 | $167 |
| Alkermes, Inc. | 1 | $130 |
| GENZYME CORPORATION | 1 | $128 |
| ABBVIE INC. | 1 | $113 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Almatica Pharma LLC | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: COBENFY, LYBALVI, CERDELGA, VRAYLAR, UZEDY, Auvelity, AUSTEDO XR, LOREEV XR.
Industry payments across NY — which companies pay providers there.
